Clostridium difficile colitis: optimizing a cost-effective approach.
Surawicz
C
C
University of Washington Seattle, USA.
D003362:Cost-Benefit Analysis; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis* / Q000191:economics; D006801:Humans; D011237:Predictive Value of Tests; D011446:Prospective Studies